Principal Investigators: William Weintraub (Thomas Jefferson School of Medicine)

Unanticipated Consequences of Proton Pump Inhibitor Use

This study investigates whether genetic variation in CYP2C19 contributes to proton pump inhibitor-associated infections and chronic illness exacerbations in children. Study aims include: 1) To compare rates of infection in healthy and obese children, and children with chronic illnesses of asthma and inflammatory bowel disease before and during treatment with proton pump inhibitors; 2) To […]

Scroll to Top